Compare FSP & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FSP | SRTS |
|---|---|---|
| Founded | 1981 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 48.1M | 48.9M |
| IPO Year | 2001 | 2016 |
| Metric | FSP | SRTS |
|---|---|---|
| Price | $0.50 | $2.86 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | ★ 284.9K | 17.2K |
| Earning Date | 04-28-2026 | 05-07-2026 |
| Dividend Yield | ★ 6.34% | N/A |
| EPS Growth | ★ 15.69 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $107,162,000.00 | $27,482,000.00 |
| Revenue This Year | $17.91 | $2.00 |
| Revenue Next Year | N/A | $34.23 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.43 | $2.66 |
| 52 Week High | $1.74 | $5.49 |
| Indicator | FSP | SRTS |
|---|---|---|
| Relative Strength Index (RSI) | 42.11 | 42.70 |
| Support Level | $0.43 | $2.87 |
| Resistance Level | $0.52 | $3.17 |
| Average True Range (ATR) | 0.03 | 0.12 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 21.72 | 18.52 |
Franklin Street Properties Corp is a real estate investment trust. The company is focused on commercial real estate investments in office markets and currently operate in only one segment: real estate operations. The principal revenue sources for its real estate operations include rental income from real estate leasing, property dispositions and fee income from asset/property management and development. The company provides asset management, property management, property accounting, investor and/or development services to its portfolio and Sponsored REIT through the company's subsidiaries.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.